“`html
carson City Teacher Finds Hope and Stability After Stem Cell Treatment Halts Multiple Sclerosis Progression
Table of Contents
A Carson City couple is celebrating a remarkable victory over multiple sclerosis, as recent medical imaging confirms zero disease progression following a specialized stem cell treatment received in Mexico.
Former Carson High School teacher Phil Brady is experiencing renewed mobility and optimism after years battling the debilitating autoimmune disease. The journey from diagnosis to treatment and back home has culminated in life-changing news for Phil and his wife, Stacie Brady. The couple returned from Clínica Ruiz in Puebla, Mexico, in august 2024, cautiously hopeful that the experimental procedure would halt the advance of his MS, which had severely limited his movement since before the COVID-19 pandemic.
A Diagnosis and a Search for Solutions
Multiple sclerosis is a condition where the body’s immune system attacks the protective myelin sheath around nerve fibers in the brain and spinal cord. Phil first experienced symptoms – including vertigo, numbness, and vision problems – approximately six years ago.The disease progressively eroded his coordination, eventually forcing him to retire from teaching. Conventional treatments, including disease-modifying drugs, offered limited relief and came with a host of side effects.
“I was on a drug that cost $6,000 a month, and it wasn’t even working,” Phil explained. “I was getting sicker and sicker.”
driven by a desire for a more effective solution, the Bradys began researching option therapies, ultimately leading them to Hematopoietic Stem Cell Transplantation (HSCT). This aggressive treatment involves harvesting a patient’s own stem cells, followed by high-dose chemotherapy to eliminate the faulty immune system, and then reinfusing the stem cells to “reset” the immune system. The procedure is not widely available in the United States, prompting the Bradys to seek treatment at Clínica Ruiz, a specialized facility in Mexico.
The treatment regimen included chemotherapy, nerve stimulation therapy, and a strict quarantine.
The financial burden of traveling to Mexico and covering the treatment costs was substantial.However,an outpouring of support from friends,family,and the wider community raised $59,000 to make the journey possible. Phil connected with fellow patients from around the globe – including individuals from California, New Zealand, Belgium, and France – forging bonds built on shared hope and resilience.
“I wont others to have the hope I’ve been given,” Brady journaled during his time in Mexico. “I want others to be able to get off the MS drugs with their side effects, low efficacy, and high price tags and get this highly effective treatment.”
Confirmation of Success: Zero New Lesions
The critical test came with an MRI, or magnetic resonance imaging, scan ordered by Phil’s neurologist.The scan, conducted at Swift Institute in Sparks, would reveal whether the HSCT had been effective in slowing or stopping the progression of the disease. This month, the Bradys received the long-awaited results.
“My specialist was so excited to call me and tell me that I have what really comes down to are zero new lesions, no new scarring … and we were super excited to hear that,” Phil said.
The MRI revealed no new areas of damage or scarring, indicating that the treatment had successfully halted the progression of his MS. While the treatment didn’t reverse existing damage, it prevented further deterioration.
A Road to Recovery and a Call for Change
The post-treatment recovery has not been without its challenges. Stacie noted a slow and steady recovery from the chemotherapy associated with the transplant, with improvements in Phil’s overall health and energy levels. However, she also observed a temporary decline in his walking ability, leading to moments of discouragement.
The MRI scan itself was a stressful experience, requiring two hours in the scanner with the use of gadolinium, a metallic agent used to enhance visibility. Phil described the contrast agent as “awful stuff that courses through your veins.”
Despite the positive outcome, Phil expressed concern about the limitations of modern American medicine in addressing MS. He believes the current approach focuses on managing symptoms with expensive medications that only slow the disease’s progress, costing patients an average of $5,000 per month.
“Ultimately, I would say it is a sad tragedy that modern American medicine does not have any clue what it’s doing about MS,” Brady stated. “All they do is provide expensive medical, expensive pills, expensive medicines which on average cost about $5,000 per month, and the only thing they promise is to slow the progress.”
Phil’s story offers a beacon of hope for individuals living with MS and underscores the need for continued research and exploration of innovative treatment options. He now looks
